Last deal

$8.6M
Local Amount - GBP 6.5M

Amount

Venture - Series Unknown

Stage

03.04.2019

Date

6

all rounds

$17.9M

Total amount

General

About Company
Oxford Genetics produces cloning plasmids for research and custom cloning and DNA synthesis services.

Industry

Sector :

Subsector :

Also Known As

OxGene

founded date

28.04.2011

Number of employees

Company Type

For Profit

Last funding type

Venture - Series Unknown

IPO status

Private

Description

OXGENE, a WuXi Advanced Therapies (WuXi ATU) company, is the headquarters for Oxford Genetics, and provides cell and gene therapy pioneers around the world with the technologies, automation platforms, and service solutions they need to develop groundbreaking therapeutics.